Board of Directors

Dr. Erich Hunziker

Chairman
read more

Dr. Erich Hunziker

Chairman
« BB Biotech is a strong growth play and it offers a high income stream on top of that »
Erich Hunziker has been on the Board of Directors of BB Biotech AG since 2011 and has been elected president in 2013. He previously served as CFO of Roche from 2001 to 2010. From 1983 to 2001 he held various executive positions at Corange, Boehringer Mannheim and, before joining Roche, at Diethelm-Keller-Gruppe, where he ultimately served as CEO. Erich Hunziker earned a Ph.D. in Industrial Engineering from the Swiss Federal Institute of Technology in Zurich. He is also a member of the Boards of Directors of AB2Bio AG and LamKap Bio AG.

Dr. Clive Meanwell

Vice Chairman
read more

Dr. Clive Meanwell

Vice Chairman
« More and more biotech firms are turning a profit. This trend should continue thanks to the full R&D pipelines »
Dr. Clive Meanwell is a member of the Board of Directors of BB Biotech AG since 2003. He is also a member of the Board of Directors and CEO of The Medicines Company, which he established in 1996. From 1995 to 1996 he was a founding partner and managing director of MPM Capital L.P. He previously held various positions at Hoffmann-La Roche in Basel and Palo Alto, California. Dr. Meanwell received his M.D. and Ph.D. from the University of Birmingham in the UK where he also trained in medical oncology.

Prof. Dr. Dr. Klaus Strein

Member
read more

Prof. Dr. Dr. Klaus Strein

Member
« Constant scrutiny of one’s own reasoning and constant effort to close any and all information gaps are the key challenges for us »
Prof. Dr. Dr. Klaus Strein has been on the Board of Directors since 2013. He was with Roche from 1998 to 2011, during which time he held various responsibilities, including head of pharma research activities in Germany and of global pharma research. From 1979 to 1998 he served in various positions at Boehringer Mannheim. He holds post-graduate degrees in chemistry and medicine from the University of Heidelberg, where he was also appointed Adjunct Professor. He is also a member of the Board of Directors of NovImmune SA and Chairman of the Board of Directors of LamKap Bio AG.